MEDIMEX: what changed
MEDIMEX
Largest movements
- Current investments -€359,594
down €359,594 (-16.8%), from €2.1m to €1.8m
- Tangible fixed assets -€73,511
down €73,511 (-65.0%), from €113,029 to €39,519
of which Furniture and vehicles: -€73,359
- Cash -€35,028
down €35,028 (-15.3%), from €228,850 to €193,822
mainly Contributions, distributions and other (-€1.1m) and Trade debts (-€24,073)
- Reserves -€477,433
down €477,433 (-21.1%), from €2.3m to €1.8m
of which Distributable reserves: -€477,433
- Other debts +€135,131
up €135,131 (+505%), from €26,779 to €161,910
- Profit (loss) carried forward -€82,014
no longer reported in 2025 (was €82,014)
- Financial income +€144,476
up €144,476 (+329%), from €43,904 to €188,380
- Gross operating margin +€79,187
up €79,187 (+13.4%), from €591,310 to €670,497
- Taxes +€64,858
up €64,858 (+37.7%), from €172,229 to €237,086
- Depreciation -€19,389
down €19,389 (-57.1%), from €33,941 to €14,553
- Write-downs +€10,403
new in 2025: €10,403
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,543,318 | €2,099,923 | -€443,395 | -17.4% |
| Fixed assets | 21/28 | €113,079 | €39,569 | -€73,511 | -65.0% |
| Tangible fixed assets | 22/27 | €113,029 | €39,519 | -€73,511 | -65.0% |
| Plant, machinery and equipment | 23 | €1,667 | €1,225 | -€442 | -26.5% |
| Furniture and vehicles | 24 | €110,819 | €37,460 | -€73,359 | -66.2% |
| Other tangible fixed assets | 26 | €543 | €834 | +€290 | +53.4% |
| Financial fixed assets | 28 | €50 | €50 | = | 0.0% |
| Current assets | 29/58 | €2,430,239 | €2,060,354 | -€369,885 | -15.2% |
| Amounts receivable within one year | 40/41 | €45,210 | €67,752 | +€22,542 | +49.9% |
| Trade receivables | 40 | €45,207 | €67,752 | +€22,545 | +49.9% |
| Other amounts receivable | 41 | €3 | - | -€3 | |
| Current investments | 50/53 | €2,145,465 | €1,785,871 | -€359,594 | -16.8% |
| Cash at bank and in hand | 54/58 | €228,850 | €193,822 | -€35,028 | -15.3% |
| Deferred charges and accrued income | 490/1 | €10,715 | €12,910 | +€2,195 | +20.5% |
| Total equity and liabilities | 10/49 | €2,543,318 | €2,099,923 | -€443,395 | -17.4% |
| Equity | 10/15 | €2,355,388 | €1,795,940 | -€559,447 | -23.8% |
| Contributions | 10/11 | €12,928 | €12,928 | = | 0.0% |
| Reserves | 13 | €2,260,446 | €1,783,013 | -€477,433 | -21.1% |
| Tax-exempt reserves | 132 | €5,541 | €5,541 | = | 0.0% |
| Distributable reserves | 133 | €2,254,905 | €1,777,472 | -€477,433 | -21.2% |
| Profit (loss) carried forward | 14 | €82,014 | - | -€82,014 | |
| Amounts payable | 17/49 | €187,931 | €303,983 | +€116,052 | +61.8% |
| Amounts payable within one year | 42/48 | €187,931 | €303,983 | +€116,052 | +61.8% |
| Trade debts | 44 | €25,809 | €1,736 | -€24,073 | -93.3% |
| Suppliers | 440/4 | €25,809 | €1,736 | -€24,073 | -93.3% |
| Taxes, remuneration and social security | 45 | €135,343 | €140,337 | +€4,994 | +3.7% |
| Taxes | 450/3 | €130,373 | €135,188 | +€4,815 | +3.7% |
| Remuneration and social security | 454/9 | €4,970 | €5,150 | +€179 | +3.6% |
| Other amounts payable | 47/48 | €26,779 | €161,910 | +€135,131 | +505% |
| Non-recurring operating income | 76A | - | €1,085 | +€1,085 | |
| Remuneration, social security and pensions | 62 | €41,830 | €46,479 | +€4,649 | +11.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €33,941 | €14,553 | -€19,389 | -57.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €10,403 | +€10,403 | |
| Other operating charges | 640/8 | €1,306 | €1,294 | -€12 | -0.9% |
| Non-recurring operating charges | 66A | - | €16,411 | +€16,411 | |
| Gross operating margin | 9900 | €591,310 | €670,497 | +€79,187 | +13.4% |
| Operating profit (loss) | 9901 | €514,233 | €581,358 | +€67,125 | +13.1% |
| Financial income | 75/76B | €43,904 | €188,380 | +€144,476 | +329% |
| Recurring financial income | 75 | €43,904 | €188,380 | +€144,476 | +329% |
| Financial charges | 65/66B | €5,094 | €10,672 | +€5,578 | +109% |
| Recurring financial charges | 65 | €5,094 | €10,672 | +€5,578 | +109% |
| Profit (loss) for the period before taxes | 9903 | €553,043 | €759,065 | +€206,022 | +37.3% |
| Income taxes | 67/77 | €172,229 | €237,086 | +€64,858 | +37.7% |
| Profit (loss) for the period | 9904 | €380,814 | €521,979 | +€141,165 | +37.1% |
| Profit (loss) for the period to be appropriated | 9905 | €380,814 | €521,979 | +€141,165 | +37.1% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.